Safety and Pharmacokinetics of Intravenous Zanamivir Treatment in Hospitalized Adults With Influenza: An Open-label, Multicenter, Single-Arm, Phase II Study

Authors
Publication date
27 August 2013
Publisher
Doi
    View on PubMed

    Abstract

    Background. Intravenous zanamivir is a neuraminidase inhibitor suitable for treatment of hospitalized patients with severe influenza

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Carolina Digital Repository

      redirect
      oaicdr.lib.unc.edu:g445cn362
      Last time updated on 24/11/2020

      ABACUS. Repositorio de Producción Científica

      redirect
      oaioai:abacus.universidadeuropea....
      Last time updated on 03/11/2021